$TFFP

Tff Pharmaceuticals Inc

  • NASDAQ
  • Health Technology
  • Pharmaceuticals: Major
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$6.09 ▲4.639%

Extented Hours

VOLUME

59,436

DAY RANGE

5.76 - 6.1

52 WEEK

3.6 - 9.96

Join Discuss about TFFP with like-minded investors

profile
@dros #droscrew
recently

+Initiations 2/8: $AAPL $AFRM $ALDX $BCEL $BTRS $ELDN $HIMS $HSIC $MIRM $MSGM $POSH $SRAX $TFFP $VSEC $WOOF $ZYME . -Initiations 2/8: $OMP

48 Replies 10 👍 14 🔥

profile
@dros #droscrew
recently

Initiations 12/7: $AXP $AYLA $CNXC $FIS $GRTX $IMAB $MA $MATN $PHGE $PRTA $SQ $TFFP $V

141 Replies 10 👍 7 🔥

Key Metrics

Market Cap

153.44 M

Beta

1.24

Avg. Volume

87.35 K

Shares Outstanding

25.45 M

Yield

0%

Public Float

0

Next Earnings Date

2022-11-14

Next Dividend Date

Company Information

TFF Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing, or TFF, technology platform. Early testing confirms that the TFF platform can significantly improve the solubility and absorption of poorly water-soluble drugs, a class of drugs that comprises approximately one-third of the major pharmaceuticals worldwide, thereby improving their pharmacokinetics. TFF Pharmaceuticals has two lead drug candidates: Voriconazole Inhalation Powder and Tacrolimus Inhalation Powder. The Company plans to add to this pipeline by collaborating with large pharmaceutical partners. The TFF Platform is protected by 42 patents issued or pending in the US and internationally.

Website:

HQ: 2600 Via Fortuna Ste 360 Austin, 78746-7983 Texas

Related News